Elsevier

Genomics

Volume 48, Issue 3, 15 March 1998, Pages 277-288
Genomics

Regular Article
Structure and Methylation-Based Silencing of a Gene (DBCCR1) within a Candidate Bladder Cancer Tumor Suppressor Region at 9q32–q33

https://doi.org/10.1006/geno.1997.5165Get rights and content

Abstract

Loss of heterozygosity (LOH) on chromosome 9q is the most frequent genetic alteration in transitional cell carcinoma (TCC) of the bladder, indicating the presence of one or more relevant tumor suppressor genes. We previously mapped one of these putative tumor suppressor loci to 9q32–q33 and localized the candidate region within a single YAC 840 kb in size. This locus has been designatedDBC1(for deleted in bladder cancer gene 1). We have identified a novel gene,DBCCR1,in this candidate region by searching for expressed sequence tags (ESTs) that map to YACs spanning the region. Database searching using the entireDBCCR1cDNA sequence identified several human ESTs and a few homologous mouse ESTs. However, the predicted 761-amino-acid sequence had no significant homology to known protein sequences. Mutation analysis of the coding region and Southern blot analysis detected neither somatic mutations nor gross genetic alterations in primary TCCs. AlthoughDBCCR1was expressed in multiple normal human tissues including urothelium, mRNA expression was absent in 5 of 10 (50%) bladder cancer cell lines. Methylation analysis of the CpG island at the 5′ region of the gene and the induction ofde novoexpression by a demethylating agent indicated that this island might be a frequent target for hypermethylation and that hypermethylation-based silencing of the gene occurs in TCC. These findings makeDBCCR1a good candidate forDBC1.

References (55)

  • K.W. Ah-See et al.

    An allelotype of squamous carcinoma of the head and neck using microsatellite markers

    Cancer Res.

    (1994)
  • A. Bairoch

    PROSITE: A dictionary of sites and patterns in proteins

    Nucleic Acids Res.

    (1992)
  • R. Berry et al.

    Gene-based sequence- tagged-sites (STSs) as the basis for a human gene map

    Nat. Genet.

    (1995)
  • P. Cairns et al.

    Frequency of homozygous deletion atp16/CDKN2

    Nat. Genet.

    (1995)
  • P. Cairns et al.

    Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas

    Cancer Res.

    (1995)
  • A. de Bustros et al.

    The short arm of chromosome 11 is a “hot spot” for hypermethylation in human neoplasia

    Proc. Natl. Acad. Sci. USA

    (1988)
  • J. Devlin et al.

    High frequency of chromosome 9 deletion in ovarian cancer: Evidence for three tumour-suppressor loci

    Br. J. Cancer

    (1996)
  • M. Gonzalez-Zulueta et al.

    Methylation of the 5′ CpG island of thep16/CDKN1

    Cancer Res.

    (1995)
  • V. Greger et al.

    Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma

    Hum. Genet.

    (1989)
  • T. Habuchi et al.

    Accumulated allelic losses in the development of invasive urothelial cancer

    Int. J. Cancer

    (1993)
  • T. Habuchi et al.

    Detailed deletion mapping of chromosome 9q in bladder cancer: Evidence for two tumour suppressor loci

    Oncogene

    (1995)
  • T. Habuchi et al.

    A novel candidate tumour suppressor locus at 9q32–33 in bladder cancer: Localisation of the candidate region within a single 840 kb YAC

    Hum. Mol. Genet.

    (1997)
  • L. Hedrick et al.

    The DCC gene product in cellular differentiation and colorectal tumorigenesis

    Genes Dev.

    (1994)
  • J.G. Herman et al.

    Silencing fo the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

    Proc. Natl. Acad. Sci. USA

    (1994)
  • J.G. Herman et al.

    Inactivation of theCDKN2/p16/MTS1

    Cancer Res.

    (1995)
  • J.G. Herman et al.

    Hypermethylation associated inactivation indicates a tumor suppressor role forp15INK4B.

    Cancer Res.

    (1996)
  • J.-P.J. Issa et al.

    Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

    Nat. Genet.

    (1994)
  • Cited by (124)

    • Neurodevelopmental MACPFs: The vertebrate astrotactins and BRINPs

      2017, Seminars in Cell and Developmental Biology
      Citation Excerpt :

      BRINP3 is overexpressed in pituitary adenomas and overexpression of BRINP3 in gonadotrope cell pituitary adenomas results in increased proliferation, migration and invasion [75]. Intriguingly, despite the very low level of expression in non-neuronal tissue [12,76], all three BRINPs have also been implicated in several different forms of non-neuronal cancer [48,49,77,78]. Additionally, BRINP2 and BRINP3 are associated with coronary heart disease [79,80] and BRINP3 (FAM5C) is a candidate gene for aggressive periodontitis [81].

    • MACPF/CDC proteins in development: Insights from Drosophila torso-like

      2017, Seminars in Cell and Developmental Biology
    View all citing articles on Scopus
    1

    Present address: Department of Urology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Kyoto 606, Japan.

    2

    To whom correspondence should be addressed at ICRF Cancer Medicine Research Unit, St. James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK. Telephone: 44-0113-2064913. Fax: 44-0113-2429886. E-mail:[email protected].

    View full text